EUVIMEDEUVIMED entdecken
Crossref

Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model

Jun-Pu Yang, Amin Ullah, Ya-Nan Su, Antonia Otoo, Enoch Appiah Adu-Gyamfi, Qian Feng, Ying-Xiong Wang, Mei-Jiao Wang, Yu-Bin Ding

Biology of Reproduction · 2023

DOI: 10.1093/biolre/ioad048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, 2023. Verfasst von Jun-Pu Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science of Foundation of China, Natural Science of Foundation of Chongqing, Chongqing Health Commission and Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to determine the impact of glycyrrhizin, an inhibitor of high mobility group box 1, on glucose metabolic disorders and ovarian dysfunction in mice with polycystic ovary syndrome. We generated a polycystic ovary syndrome mouse model by using dehydroepiandrosterone plus high-fat diet. Glycyrrhizin (100 mg/kg) was intraperitoneally injected into the polycystic ovary syndrome mice and the effects on body weight, glucose tolerance, insulin sensitivity, estrous cycle, hormone profiles, ovarian pathology, glucolipid metabolism, and some molecular mechanisms were investigated. Increased number of cystic follicles, hormonal disorders, impaired glucose tolerance, and decreased insulin sensitivity in the polycystic ovary syndrome mice were reverted by glycyrrhizin. The increased high mobility group box 1 levels in the serum and ovarian tissues of the polycystic ovary syndrome mice were also reduced by glycyrrhizin. Furthermore, increased expressions of toll-like receptor 9, myeloid differentiation factor 88, and nuclear factor kappa B as well as reduced expressions of insulin receptor, phosphorylated protein kinase B, and glucose transporter type 4 were restored by glycyrrhizin in the polycystic ovary syndrome mice. Glycyrrhizin could suppress the polycystic ovary syndrome-induced upregulation of high mobility group box 1, several inflammatory marker genes, and the toll-like receptor 9/myeloid differentiation factor 88/nuclear factor kappa B pathways, while inhibiting the insulin receptor/phosphorylated protein kinase B/glucose transporter type 4 pathways. Hence, glycyrrhizin is a promising therapeutic agent against polycystic ovary syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceFemaleHumansMiceAnimalsProto-Oncogene Proteins c-aktReceptor, InsulinGlycyrrhizic AcidToll-Like Receptor 9NF-kappa BGlucose Transporter Type 4Myeloid Differentiation Factor 88InsulinGlucose

Stichwörter der Autor:innen

glycyrrhizinhigh mobility group box 1insulin resistanceovarian dysfunctionpolycystic ovary syndrome

Substanzen

Proto-Oncogene Proteins c-aktReceptor, InsulinGlycyrrhizic AcidToll-Like Receptor 9NF-kappa BGlucose Transporter Type 4Myeloid Differentiation Factor 88InsulinGlucose

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA, USA.
  • Department of Obstetrics and Gynecology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
  • Department of Physiology, School of Basic Medical Science, Chongqing Medical University, Chongqing, China.
  • Department of Toxicology, School of Public Health, Chongqing Medical University, Chongqing, China.
  • Department of Pharmacology, Academician Workstation, Changsha Medical University, Changsha, China.

Förderung

  • National Natural Science of Foundation of China
  • Natural Science of Foundation of Chongqing
  • Chongqing Health Commission and Science and Technology

Zitieren

APA

Yang, J. P., Ullah, A., Su, Y. N., Otoo, A., Adu-Gyamfi, E. A., Feng, Q., Wang, Y. X., Wang, M. J., & Ding, Y. B. (2023). Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model. Biology of Reproduction. https://doi.org/10.1093/biolre/ioad048

Vancouver

Yang JP, Ullah A, Su YN, Otoo A, Adu-Gyamfi EA, Feng Q, et al. Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model. Biology of Reproduction. 2023. doi:10.1093/biolre/ioad048

BibTeX
@article{Yang2023,
  author = {Yang, Jun-Pu and Ullah, Amin and Su, Ya-Nan and Otoo, Antonia and Adu-Gyamfi, Enoch Appiah and Feng, Qian and Wang, Ying-Xiong and Wang, Mei-Jiao and Ding, Yu-Bin},
  title = {Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model},
  journal = {Biology of Reproduction},
  year = {2023},
  doi = {10.1093/biolre/ioad048}
}
Kostenlos starten →